373 related articles for article (PubMed ID: 31128115)
1. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis.
Yang M; Shen Y; Tan L; Li W
Chest; 2019 Jul; 156(1):101-111. PubMed ID: 31128115
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis.
Deng HY; Hou L; Zha P; Huang KL; Peng L
Eur J Surg Oncol; 2019 May; 45(5):728-735. PubMed ID: 30348603
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
7. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis.
Hu Y; Shen J; Liu R; Feng Z; Zhang C; Ling L; Chen L
Int J Biol Markers; 2018 Nov; 33(4):372-378. PubMed ID: 30282502
[TBL] [Abstract][Full Text] [Related]
9. Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
Shinohara S; Otsuki R; Kobayashi K; Sugaya M; Matsuo M; Nakagawa M
Ann Surg Oncol; 2020 Jul; 27(7):2427-2435. PubMed ID: 31970570
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
12. Tumor Spread Through Air Spaces Is a Survival Predictor in Non-Small-Cell Lung Cancer.
Wang S; Hao J; Qian C; Wang H
Clin Lung Cancer; 2019 Sep; 20(5):e584-e591. PubMed ID: 31230891
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
[TBL] [Abstract][Full Text] [Related]
14. Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
Rossi S; Di Noia V; Tonetti L; Strippoli A; Basso M; Schinzari G; Cassano A; Leone A; Barone C; D'Argento E
Future Oncol; 2018 Apr; 14(10):919-926. PubMed ID: 29528255
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Bi G; Yao G; Bian Y; Xue L; Zhang Y; Lu T; Fan H
Ann Thorac Cardiovasc Surg; 2020 Feb; 26(1):1-12. PubMed ID: 31588071
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis.
Zhou J; Lin Z; Lyu M; Chen N; Liao H; Wang Z; Hao J; Yan C; Liu L
Jpn J Clin Oncol; 2020 Jan; 50(1):44-57. PubMed ID: 31735973
[TBL] [Abstract][Full Text] [Related]
19. The Role of Baseline Sarcopenia Index in Predicting Chemotherapy-Induced Undesirable Effects and Mortality in Older People with Stage III or IV Non-Small Cell Lung Cancer.
Chen X; Hou L; Shen Y; Wu X; Dong B; Hao Q
J Nutr Health Aging; 2021; 25(7):878-882. PubMed ID: 34409965
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
